MTCYBP41

Across TCGA pan-cancer cohorts, MTCYBP41 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MTCYBP41’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where MTCYBP41 RNA is repressed in tumor relative to normal tissue. In most cancer types MTCYBP41 is over-expressed in tumor, although a few such as LUSC and ESCA show the opposite, repressed pattern.

LUSC, LIHC, and ESCA are the cancer types where MTCYBP41 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTCYBP41 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	II,III,IV	−0.034	.010	3	view →
LIHC	All	All	+0.033	.030	2	view →
ESCA	All	All	−0.086	.028	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MTCYBP41–LUSC

Open the LUSC breakdown →